| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 5001 |
T Regulatory Cell Activation Exists in Pathogenesis of Polycythaemia Vera.
|
Wang, Xin
|
|
|
110 |
11 |
p. 4642
|
artikel
|
| 5002 |
T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.
|
Torelli, Giovanni F.
|
|
|
110 |
11 |
p. 4862
|
artikel
|
| 5003 |
Trend and Geographic Variations in the Incidence of Mantle Cell Lymphoma in the United States over 30 Years from 1975 to 2004.
|
Zhou, Yuhong
|
|
|
110 |
11 |
p. 4414
|
artikel
|
| 5004 |
Trend and Geographic Variations in the Incidence of Waldenstrom's Macroglobulinemia in the United States over 17 Years from 1988 to 2004.
|
Wang, Michael
|
|
|
110 |
11 |
p. 5174
|
artikel
|
| 5005 |
Trend in Prevalence of Human T-Lymphotropic Virus Type-1 (HTLV-1) Infection in Japanese Blood Donors, Nagasaki, 1999 to 2006.
|
Iwanaga, Masako
|
|
|
110 |
11 |
p. 2911
|
artikel
|
| 5006 |
Triad1 Regulates Myelopoiesis through Different Ubiquitin Ligase Activities.
|
van der Reijden, Bert A.
|
|
|
110 |
11 |
p. 3292
|
artikel
|
| 5007 |
Triple Combinations of the HDAC Inhibitor Panobinostat (LBH589) + Dexamethasone with Either Lenalidomide or Bortezomib Are Highly Effective in a Multiple Myeloma Mouse Model.
|
Ocio, Enrique M.
|
|
|
110 |
11 |
p. 1514
|
artikel
|
| 5008 |
Triptolide Induces Cell Death Independent of Cellular Responses to Imatinib in Blast Crisis CML Cells and Sensitizes Imatinib.
|
Mak, Duncan H.
|
|
|
110 |
11 |
p. 1610
|
artikel
|
| 5009 |
Trisomy 13, AML1 Mutations and M0 Subtype Are Remarkably Intricate Events in Acute Myeloid Leukemia (AML).
|
Nibourel, Olivier
|
|
|
110 |
11 |
p. 4250
|
artikel
|
| 5010 |
Truncated Human Erythropoietin Receptor Causes Fetal Polycythemia and Is Associated with a Prolonged Primitive Erythropoiesis and Hyperactive Definitive Erythropoiesis.
|
Yoon, Donghoon
|
|
|
110 |
11 |
p. 3664
|
artikel
|
| 5011 |
Truncations in CCND1 mRNA 3′ UTR Alters microRNA Regulation in Mantle Cell Lymphoma.
|
Chen, Robert W.
|
|
|
110 |
11 |
p. 3184
|
artikel
|
| 5012 |
Tumor Associated Macrophages (TAM) in Skeletal Plasmacytomas of Patients with Multiple Myeloma.
|
Russell, Stephen J.
|
|
|
110 |
11 |
p. 114
|
artikel
|
| 5013 |
Tumor Necrosis Factor-α Enhances DMSO-Induced Differentiation of HL-60 Cells through Activation of ERK/MAPK Pathway.
|
Park, Jinny
|
|
|
110 |
11 |
p. 4386
|
artikel
|
| 5014 |
Tumor Suppressor Activity of CCAAT/Enhancer Binding Protein Alpha Is Epigenetically Down-Regulated in Acute Myeloid Leukemia.
|
Lin, Tsung-Chin
|
|
|
110 |
11 |
p. 2113
|
artikel
|
| 5015 |
Tumour Burden Influence on Individual Rituximab Exposure and Response: Pharmacokinetic - Pharmacodynamic Approach by Using a Syngenic Bioluminescent Murine Model.
|
Daydé, David
|
|
|
110 |
11 |
p. 2347
|
artikel
|
| 5016 |
Twenty-Seven Percent of Children with Congenital Heart Disease Have a Thrombotic Event Detected in the Post Operative Period: A Prospective Cohort Study.
|
Mitchell, Lesley G.
|
|
|
110 |
11 |
p. 1636
|
artikel
|
| 5017 |
Twisted Gastrulation (TWSG1) Is Expressed at Elevated Levels in Thalassemia and Regulates Bone Morphogenic Protein Signaling.
|
Tanno, Toshihiko
|
|
|
110 |
11 |
p. 1785
|
artikel
|
| 5018 |
Twist Is Required for Thrombin-Induced Tumor Angiogenesis as Well as Migration.
|
Hu, Liang
|
|
|
110 |
11 |
p. 406
|
artikel
|
| 5019 |
Two Cases of Chronic Active Epstein-Barr Virus Infection (CAEBV) Successfully Treated with Allogeneic Bone Marrow Transplantation and Induction of Specific Cytotoxic T Lymphocyte (CTL).
|
Miyamura, Takako
|
|
|
110 |
11 |
p. 5040
|
artikel
|
| 5020 |
Two Classes of Progenitor Cells in Patients with Myeloproliferative Disorders Are Capable of Generating JAK2V617F+CD31+CD144+ Endothelial Cells.
|
Sozer, Selcuk
|
|
|
110 |
11 |
p. 261
|
artikel
|
| 5021 |
Two Distinct Mechanisms Are Responsible for Regulation of Ribosomal Protein S19 Expression Level in Diamond-Blackfan Anemia by NF-κB Pathway.
|
Hurtaud, Corinne
|
|
|
110 |
11 |
p. 1684
|
artikel
|
| 5022 |
Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children's Oncology Group.
|
Gastier-Foster, Julie M.
|
|
|
110 |
11 |
p. 1439
|
artikel
|
| 5023 |
Two-Hybrid Screening Identifies an Interaction between the CUB Domains of Human ADAMTS13 and Factor XII.
|
Yu, Zheyong
|
|
|
110 |
11 |
p. 1741
|
artikel
|
| 5024 |
Two Novel Translocations That Disrupt the RUNX1 Gene in Acute Myeloid Leukemia.
|
Dai, Haiping
|
|
|
110 |
11 |
p. 4127
|
artikel
|
| 5025 |
Two-Stage Pharmacokinetic & Efficacy Study of Lenalidomide Alone or Combined with Recombinant Erythropoietin (EPO) in Lower Risk MDS EPO-Failures [PK-002].
|
List, Alan F.
|
|
|
110 |
11 |
p. 4626
|
artikel
|
| 5026 |
Type 2B “Malmo/New York” Is Not So Rare among Italian Patients with von Willebrand Disease: The Role of P1266L/Q Mutations of the von Willebrand Factor Gene in Seven Cases.
|
Baronciani, Luciano
|
|
|
110 |
11 |
p. 712
|
artikel
|
| 5027 |
Tyrosine Kinase Inhibition by SU5614 Fails To Eradicate Leukemic Stem Cells in FLT3-ITD+ Acute Myeloid Leukemia: Role of the Microenvironment.
|
Götze, Katharina S.
|
|
|
110 |
11 |
p. 3382
|
artikel
|
| 5028 |
Tyrosine Kinase Inhibitors Dasatinib, Nilotinib and Imatinib Have an Impact on Both CD8+ T Lymphocytes and CD4+CD25+FoxP3+ Regulatory T Cells by Downregulation of the NF-κB Pathway.
|
Fei, Fei
|
|
|
110 |
11 |
p. 2368
|
artikel
|
| 5029 |
Tyrosine Kinase Inhibitors Only Partially Inhibit AKT-Dependent Signaling in Cells Expressing Oncogenic KIT, FLT3 or ABL Kinases. A Potential Model for Leukemia Cell Resistance to TKIs.
|
Schittenhelm, Marcus M.
|
|
|
110 |
11 |
p. 2370
|
artikel
|
| 5030 |
Ubenimex Enhances the Gemtuzumab Ozogamicin-Induced Cytotoxicity Against Myeloid Leukemia Cells.
|
Takamatsu, Yasushi
|
|
|
110 |
11 |
p. 4370
|
artikel
|
| 5031 |
UGT1A1 Gene Polymorphisms & A(TA)nTAA Promoter Configurations in Omani Sickle Cell Disease Patients.
|
AlKindi, Salam
|
|
|
110 |
11 |
p. 3786
|
artikel
|
| 5032 |
Ultrasound Guided Core Biopsy of the Spleen in Lymphoma Diagnosis.
|
Miall, Fiona M.
|
|
|
110 |
11 |
p. 4404
|
artikel
|
| 5033 |
Umbilical Cord Blood T Cells Express the Natural Cytotoxicity Receptors, NKp30, NKp44 and NKp46 after IL-15 Stimulation, but Only NKp30 Is Functional.
|
Tang, Qin
|
|
|
110 |
11 |
p. 61
|
artikel
|
| 5034 |
Umbilical Cord Blood Transplantation after Reduced-Intensity Conditioning for Adults: The Report from Japan Cord Blood Bank Network.
|
Matsuno, Naofumi
|
|
|
110 |
11 |
p. 2030
|
artikel
|
| 5035 |
Unacceptable Toxicity of Lenalidomide When Administered to CLL Patients at Higher Doses.
|
Andritsos, Leslie A.
|
|
|
110 |
11 |
p. 4727
|
artikel
|
| 5036 |
Uncommon Mutations in PML-RARα Associated with Poor Outcome after First Relapse in APL.
|
Schachter-Tokarz, Esther
|
|
|
110 |
11 |
p. 4248
|
artikel
|
| 5037 |
Uncovering the Epigenetic Pathomechanism in 13q14.
|
Mertens, Daniel
|
|
|
110 |
11 |
p. 487
|
artikel
|
| 5038 |
Understanding the Factor Va Cofactor Effect within Prothrombinase.
|
Kalafatis, Michael
|
|
|
110 |
11 |
p. 2700
|
artikel
|
| 5039 |
Unexpected Toxicity with Intensified Induction in Infant Acute Lymphoid Leukemia.
|
Dreyer, Zoann Eckert
|
|
|
110 |
11 |
p. 852
|
artikel
|
| 5040 |
Unfavourable Outcome and Heterogeneity of Partner Chromosomes in Chronic Lymphocytic Leukemia with 14q32/IGH Translocations.
|
Cavazzini, Francesco
|
|
|
110 |
11 |
p. 4686
|
artikel
|
| 5041 |
Unique Pattern of Raf-1 Kinase Inhibitory Protein (RKIP) Expression in Multiple Myeloma (MM) Compared to Other Tumor Types: Overexpression of RKIP and a Phosphorylated RKIP Is Common in MM Tumor Cells.
|
Baritaki, Stavroula
|
|
|
110 |
11 |
p. 4852
|
artikel
|
| 5042 |
Unique Resistance Mechanism to Dexamethasone by Glutathione S-Transferase M1 Involving p38 MAPK and NF-κB Pathways, Possible Prognostic Role for Childhood ALL.
|
Hosono, Naoko
|
|
|
110 |
11 |
p. 2375
|
artikel
|
| 5043 |
Universal CD160 Expression and the CD5+23+ / CD5+19+ Ratio in Chronic Lymphocytic Leukemia Simplfy Identification of Atypical Cases from CD23+ Mantle Cell Lymphoma.
|
Tsitsikas, Dimitris A.
|
|
|
110 |
11 |
p. 4678
|
artikel
|
| 5044 |
Universal Thrombophilia Screening Not Cost-Effective for Determining Duration of Anticoagulation in Pediatric Patients.
|
O'Brien, Sarah H.
|
|
|
110 |
11 |
p. 970
|
artikel
|
| 5045 |
Universal Thrombophilia Screening with Risk Stratification and Anticoagulation Management in Pediatric Renal Transplant Recipients.
|
Saxena, Kapil
|
|
|
110 |
11 |
p. 4011
|
artikel
|
| 5046 |
Unlike Imatinib, Dasatinib Uptake into Chronic Myeloid Leukaemia Cells Is Independent of hOCT1 Expression.
|
Giannoudis, Athina
|
|
|
110 |
11 |
p. 3458
|
artikel
|
| 5047 |
Unlike Inactivating PTEN Mutations, Pharmacological Inhibition of PTEN Does Not Increase the Sensitivity of Multiple Myeloma Cells to Inhibition of the PI3K/Akt/mTOR Pathway.
|
Wang, Xiaojing
|
|
|
110 |
11 |
p. 4785
|
artikel
|
| 5048 |
Unrelated Allogeneic Stem Cell Transplantation with Myeloablative Conditioning in Adults with Acute Lymphoblastic Leukemia in Remission: Peripheral Blood or Bone Marrow?.
|
Basara, Nadezda
|
|
|
110 |
11 |
p. 174
|
artikel
|
| 5049 |
Unrelated Cord Blood Cell Transplantation for Acquired Severe Aplastic Anemia: The Report from the Japan Cord Blood Bank Network.
|
Kojima, Seiji
|
|
|
110 |
11 |
p. 2020
|
artikel
|
| 5050 |
Unrelated Cord Blood Transplanation for Malignant Lymphoma: A Retrospective Study from the Japan Cord Blood Bank Network (JCBNW).
|
Takita, Morihito
|
|
|
110 |
11 |
p. 2026
|
artikel
|
| 5051 |
Unrelated Cord Blood Transplantation after Reduced Intensity Conditioning (RIC) in Adults with Hematological Malignancy. An EBMT-Eurocord-Netcord, Société Française de Greffe de Moelle et de Thérapie Cellulaire and University of Minnesota Collaborative Study.
|
Rocha, Vanderson
|
|
|
110 |
11 |
p. 2027
|
artikel
|
| 5052 |
Unrelated Cord Blood Transplantation for Children with Juvenile Myelomonocytic Leukemia.
|
Locatelli, Franco
|
|
|
110 |
11 |
p. 2021
|
artikel
|
| 5053 |
Unrelated Cord Blood Transplantation Using Myeloablative Regimen for Acute Leukemia Patients Aged between 50 and 55 Years: Single Institutional Retrospective Comparison with Patients Less Than 50 Years of Age.
|
Konuma, Takaaki
|
|
|
110 |
11 |
p. 2013
|
artikel
|
| 5054 |
Unrelated Cord Blood Transplants in Children/Adolescents in Multi-Racial Singapore.
|
Tan, Poh-Lin
|
|
|
110 |
11 |
p. 5089
|
artikel
|
| 5055 |
Unrelated Donor Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in First Complete Remission.
|
Huang, He
|
|
|
110 |
11 |
p. 5077
|
artikel
|
| 5056 |
Unrelated Donor Transplants for Severe Aplastic Anemia: A Report from the EBMT SAA Working Party.
|
Bacigalupo, Andrea
|
|
|
110 |
11 |
p. 3054
|
artikel
|
| 5057 |
Unrelated Donor Umbilical Cord Blood Transplantation (UD-UCBT) for Adult Patients with High-Risk Acute Lymphoblastic Leukemia (ALL).
|
Sanz, Jaime
|
|
|
110 |
11 |
p. 2024
|
artikel
|
| 5058 |
Unrelated Donor (URD) Hematopoietic Stem Cell Transplantation (HCT) for Adults with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR1): A Center for International Blood and Marrow Transplant Research (CIBMTR) Analysis.
|
Marks, David I.
|
|
|
110 |
11 |
p. 3055
|
artikel
|
| 5059 |
Unrelated Donor (URD) Searches in African-Americans with Hematologic Malignancies: Paucity of HLA Identical Donors.
|
Dew, Alexander
|
|
|
110 |
11 |
p. 5064
|
artikel
|
| 5060 |
Untreated Patients with Acute Myeloid Leukemia, Age 50–59 Years and Performance Status 2 Should Be as Eligible for Targeted Therapy as Older Patients.
|
Tsimberidou, Apostolia M.
|
|
|
110 |
11 |
p. 2864
|
artikel
|
| 5061 |
Unusual Immunophenotypes in the Bone Marrow of Infants with Acute Leukemia: Minimal Residual Disease or ATRA-Mediated Regeneration?.
|
Popov, Alexander
|
|
|
110 |
11 |
p. 4260
|
artikel
|
| 5062 |
Updated Analysis of Allogeneic HSCT after RIC for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.
|
Michallet, Mauricette
|
|
|
110 |
11 |
p. 1085
|
artikel
|
| 5063 |
Updated Results of High-Dose Yttrium 90 (90Y) Ibritumomab Tiuxetan with High-Dose Etoposide (VP-16) and Cyclophosphamide (CY) Followed by Autologous Hematopoietic Cell Transplant (AHSCT) for Poor-Risk or Refractory B-Cell Non-Hodgkin's Lymphoma.
|
Nademanee, Auayporn
|
|
|
110 |
11 |
p. 1891
|
artikel
|
| 5064 |
Updated Survival Analyses after Prolonged Follow-Up of the Phase 2, Multicenter CREST Study of Bortezomib in Relapsed or Refractory Multiple Myeloma.
|
Jagannath, Sundar
|
|
|
110 |
11 |
p. 2717
|
artikel
|
| 5065 |
Update of a GITIL Cohort Study: Frontline High Dose Sequential Chemotherapy with Rituximab and Autologous Stem Cell Transplantation Induces a High Rate of Long-Term Remissions in Patients with Mantle Cell Lymphoma
|
Cortelazzo, Sergio
|
|
|
110 |
11 |
p. 1282
|
artikel
|
| 5066 |
Update of a Phase I Study of Sorafenib in Patients with Refractory/Relapsed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome.
|
Delmonte Jr., John
|
|
|
110 |
11 |
p. 893
|
artikel
|
| 5067 |
Update of Experience with Fludarabine, Cyclophosphamide, Mitoxantrone Plus Rituximab (FCM-R) in Frontline Therapy for Chronic Lymphocytic Leukemia (CLL).
|
Faderl, Stefan
|
|
|
110 |
11 |
p. 627
|
artikel
|
| 5068 |
Update of the Modified Hyper-CVAD Regimen with or without Rituximab as Frontline Therapy of Adults with Acute Lymphocytic Leukemia (ALL) or Lymphoblastic Lymphoma (LL).
|
Thomas, Deborah A.
|
|
|
110 |
11 |
p. 2824
|
artikel
|
| 5069 |
Up-Regulated WRN and DNA Ligase IIIα Are Involved in Alternative NHEJ Repair Pathway of DNA Double Strand Breaks (DSB) in Chronic Myeloid Leukemia (CML).
|
Sallmyr, Annahita
|
|
|
110 |
11 |
p. 1016
|
artikel
|
| 5070 |
Upregulation of CXCR4 Is Essential for the Migration and Survival of Quiescent CML Progenitor Cells in the Bone Marrow Microenvironment after Imatinib Treatment.
|
Tabe, Yoko
|
|
|
110 |
11 |
p. 1004
|
artikel
|
| 5071 |
Upregulation of Microparticles and CD40 Ligand in Antiphospholipid Syndrome: Potential Implication in Inflammatory Responses and Thrombosis.
|
Fabbrini, Nancy
|
|
|
110 |
11 |
p. 1740
|
artikel
|
| 5072 |
Up-Regulation of miR-195 Expression Leads to Decreased Expression of Basic Fibroblast Growth Factor in CLL Patients Treated with DNA Methylation Inhibitors.
|
Phillips, John D.
|
|
|
110 |
11 |
p. 3183
|
artikel
|
| 5073 |
Urokinase (uPA) Induces Endothelial Cell Survival Via the X-Linked Inhibitor of Apoptosis Protein (XIAP).
|
Prager, Gerald W.
|
|
|
110 |
11 |
p. 3712
|
artikel
|
| 5074 |
Use of a Lentiviral Vector Encoding γ-Globin and the MGMT Drug Resistance Gene Coupled with In Vivo Drug Selection To Cure β-Thalassemia.
|
Zhao, Huifen
|
|
|
110 |
11 |
p. 1773
|
artikel
|
| 5075 |
Use of Chromosome Engineering To Model a Leukemia-Associated 7q22 Deletion in the Mouse.
|
Wong, Jasmine C.
|
|
|
110 |
11 |
p. 2654
|
artikel
|
| 5076 |
Use of Dexamethasone Given to Sibling Donors as a Way of In Vivo Purging of Allo Reactive Donor T Cells in rhg-CSF Mobilized Peripheral Blood Stem Cell Transplantations Resulted in Significant Decrease in CD3+ Cells and Increased CD34+ Yield.
|
Ashraf, Khaleel K.
|
|
|
110 |
11 |
p. 3047
|
artikel
|
| 5077 |
Use of Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolic Events in Acutely Ill Medical Patients: A Meta-Analysis of Individual Patient Data.
|
Mismetti, Patrick
|
|
|
110 |
11 |
p. 1859
|
artikel
|
| 5078 |
Use of Gene-Modified T-Cells as Antigen Presenting Cells (T-APC) for Vaccination Against Myeloma Antigens.
|
Anderson Jr, Larry D.
|
|
|
110 |
11 |
p. 2758
|
artikel
|
| 5079 |
Use of Interleukin 6, High Sensitivity CRP, TNFα and Procalcitonin as Early Markers of Sepsis in Febrile Neutropenic Children.
|
Kharya, Gaurav
|
|
|
110 |
11 |
p. 3852
|
artikel
|
| 5080 |
Use of Intravenous Busulphan for Reduced Intensity Conditioning (RIC) Haematopoietic Stem Cell Transplantation (HSCT) Is Associated with Delayed T-Cell Full Donor Chimerism and Lower Incidence of Acute Graft Versus Host Disease.
|
Lim, ZiYi
|
|
|
110 |
11 |
p. 1994
|
artikel
|
| 5081 |
Use of Mesenchymal Stem Cells To Treat Pediatric Patients with Severe (Grade III–IV) Acute Graft Versus Host Disease Refractory to Steroid and Other Agents on a Compassionate Use Basis.
|
Prasad, Vinod K.
|
|
|
110 |
11 |
p. 2971
|
artikel
|
| 5082 |
Use of Mouse Embryonic Stem Cell Differentiation To Model Primitive Erythropoiesis In Vitro.
|
Morgan, Brian B.
|
|
|
110 |
11 |
p. 1269
|
artikel
|
| 5083 |
Use of Palifermin for the Prevention of High-Dose Methotrexate-Induced Oral Mucositis.
|
Schmidt, Eva
|
|
|
110 |
11 |
p. 4445
|
artikel
|
| 5084 |
Use of Post-Treatment Clinical Data To Predict Response to Decitabine.
|
Estey, Elihu
|
|
|
110 |
11 |
p. 1448
|
artikel
|
| 5085 |
Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS).
|
Dale, Janet K.
|
|
|
110 |
11 |
p. 1319
|
artikel
|
| 5086 |
Use of Single Course IV Fludarabine in Treatment of Hypocellular Bone Marrow (Aplastic Anaemia and MDS) Patients.
|
Apte, Shashikant J.
|
|
|
110 |
11 |
p. 4047
|
artikel
|
| 5087 |
Use of Third Party Ancillary Cells for Enhancement of Full Donor Chimerism and Immunomodulation in Cord Blood Transplants.
|
Fernandez, Manuel N.
|
|
|
110 |
11 |
p. 335
|
artikel
|
| 5088 |
USF1 Recruits hSET1 Complex and Is Important for Maintaining Active Chromatin Domains in the β-Globin Locus.
|
Li, Xingguo
|
|
|
110 |
11 |
p. 274
|
artikel
|
| 5089 |
Using CD160 as a Novel Approach to the Assessment of Minimal Residual Disease (MRD) in Chronic Lymphocytic Leukaemia (CLL).
|
Farren, Timothy
|
|
|
110 |
11 |
p. 2036
|
artikel
|
| 5090 |
U.S. Inhibitor Pilot Project: Participant Characteristics and Infusion Log Adherence.
|
Creary, Melissa S.
|
|
|
110 |
11 |
p. 1162
|
artikel
|
| 5091 |
Usual Clinical Parameters Underestimate the Incidence and Significance of Erythropoietin Deficiency as a Risk Factor for Death in Sickle Cell Disease.
|
Saraf, Santosh
|
|
|
110 |
11 |
p. 3791
|
artikel
|
| 5092 |
Utilization of Darbepoetin alfa in Relation to Cancer Patients' Hemoglobin Levels.
|
Hess, Gregory
|
|
|
110 |
11 |
p. 3756
|
artikel
|
| 5093 |
Utilization of ‘Rainy Day' Autologous Peripheral Blood Stem Cells.
|
Wall, Dominic
|
|
|
110 |
11 |
p. 4913
|
artikel
|
| 5094 |
Utilization of Resources and Overall Outcome in Patients Undergoing Hematopoietic Stem Cell Transplantation Related to Psychosocial Factors as Measured by the Transplant Evaluation Rating Scale (TERS).
|
Speckhart, Dawn S.
|
|
|
110 |
11 |
p. 3332
|
artikel
|
| 5095 |
Utlilizing Mutant Mice To Dissect Immune Bone Marrow Failure: Markedly Reduced Cytotoxicity of Lymphocytes from Fas- and Fas Ligand-Deficient Mice in Lymph Node Cell-Mediated Aplastic Anemia.
|
Omokaro, Stephanie O.
|
|
|
110 |
11 |
p. 3882
|
artikel
|
| 5096 |
Vaccination of Acute Myeloid Leukemia Patients with Dendritic Cells Electroporated with mRNA Encoding the Wilms' Tumor Protein WT1: A Phase I/II Trial.
|
Berneman, Zwi N.
|
|
|
110 |
11 |
p. 158
|
artikel
|
| 5097 |
Vaccination of B-CLL Patients with Autologous Dendritic Cells Results in Immunological and Clinical Responses.
|
Hus, Iwona
|
|
|
110 |
11 |
p. 2052
|
artikel
|
| 5098 |
Vaccination with DC/Multiple Myeloma Fusions in Conjunction with Stem Cell Transplantation.
|
Avigan, David
|
|
|
110 |
11 |
p. 578
|
artikel
|
| 5099 |
Vaccine Efficacy Following Autologous Peripheral Blood Stem Cell Transplant for Lymphoma.
|
Small, Trudy N.
|
|
|
110 |
11 |
p. 603
|
artikel
|
| 5100 |
Validation of a Pretransplantation Assessment of Mortality (PAM) Score for Predicting Risk of Death in the First Two Years after Allogeneic Hematopoietic Cell Transplantation in a Tertiary Transplant Center.
|
Chopra, Akhil
|
|
|
110 |
11 |
p. 1987
|
artikel
|
| 5101 |
Validation of the International Scale for Measurement of BCR-ABL by RQ-PCR Based on Deriving Laboratory-Specific Conversion Factors.
|
Branford, Susan
|
|
|
110 |
11 |
p. 1013
|
artikel
|
| 5102 |
Valproate, a Histone Deacetylase Inhibitor, Enhances Purine Nucleoside Analogues Induced Apoptosis of B-Chronic Lymphocytic Leukemia Cells.
|
Bouzar, Amel B.
|
|
|
110 |
11 |
p. 4712
|
artikel
|
| 5103 |
Valproic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells by Targeting Several Pro- and Anti-Apoptotic Genes.
|
Stamatopoulos, Basile
|
|
|
110 |
11 |
p. 3131
|
artikel
|
| 5104 |
Valves of the Deep Venous System: The Overlooked Risk Factor.
|
Brooks, Erin
|
|
|
110 |
11 |
p. 1629
|
artikel
|
| 5105 |
Variability of CD36 Expression on Platelets Is Determined in Part by Genetic Polymorphisms and Can Influence Platelet Function.
|
Ghosh, Arunima
|
|
|
110 |
11 |
p. 3643
|
artikel
|
| 5106 |
Variable but Consistent Pattern of Meningioma 1 Gene (MN1) Expression in Different Genetic Subsets of Acute Myelogenous Leukaemia and Its Potential Use as Marker for Minimal Residual Disease Detection.
|
Cilloni, Daniela
|
|
|
110 |
11 |
p. 3494
|
artikel
|
| 5107 |
Variable Contribution of Different Monocloncal Antibodies to NK Cell-Mediated ADCC Against Primary CLL Cells.
|
Weitzman, James
|
|
|
110 |
11 |
p. 4715
|
artikel
|
| 5108 |
Variance in Outcomes by Physician Providers for Patients with Non-Hodgkin's Lymphoma.
|
Dillman, Robert O.
|
|
|
110 |
11 |
p. 4410
|
artikel
|
| 5109 |
Variants of Recombinant Factor IX with Enhanced Functional Properties.
|
Hartmann, Rudolf
|
|
|
110 |
11 |
p. 2694
|
artikel
|
| 5110 |
Variation in the Small Guanosine Triphosphate (GTP)-Binding Protein, Secretion-Associated and RAS-Related (SAR1A) Gene and Response to Hydroxyurea Treatment in Sickle Cell Disease.
|
Kumkhaek, Chutima
|
|
|
110 |
11 |
p. 3392
|
artikel
|
| 5111 |
Variation of Sorcin's Expression in the Reversion of Multidrug Resistance of K562/A02 Leukemic Line with Tetrandrine.
|
Chen, Bao-An Chen
|
|
|
110 |
11 |
p. 4176
|
artikel
|
| 5112 |
Varicella Zoster Virus Reactivation with the Use of Bortezomib in Relapsed or Refractory Multiple Myeloma Patients.
|
Kim, Seok Jin
|
|
|
110 |
11 |
p. 4843
|
artikel
|
| 5113 |
Varying Levels of CD34 Expression Correlate with Maintenance and Differentiation of HSC/MPP-Like Cell Line EML.
|
Zayas, Jennifer
|
|
|
110 |
11 |
p. 4050
|
artikel
|
| 5114 |
Vascular Consequences of Cocaine Exposure.
|
Hobbs, William E.
|
|
|
110 |
11 |
p. 3718
|
artikel
|
| 5115 |
Vascular Dysfunction in Murine Models of Hemolytic Anemia.
|
Wandersee, Nancy J.
|
|
|
110 |
11 |
p. 846
|
artikel
|
| 5116 |
Vascular Endothelial Growth Factor Receptor-1 (VEGFR-1) Expression Is Increased in Ph−Chronic Myeloproliferative Disorders and Correlates with the Microvessel Density and VEGF.
|
Deliliers, Giorgio Lambertenghi
|
|
|
110 |
11 |
p. 1554
|
artikel
|
| 5117 |
Vascularization Predicts Overall Survival (OS) & Risk of Transformation (RT) in Uniformly Treated Patients with Follicular Lymphoma (FL).
|
Farinha, Pedro
|
|
|
110 |
11 |
p. 184
|
artikel
|
| 5118 |
VEGF-A, VEGF-C, and CD31 Expression by Leukemia Cells Are Prognostic Factors for Overall Survival in Acute Myeloid Leukemia (AML).
|
Wang, Eunice S.
|
|
|
110 |
11 |
p. 2392
|
artikel
|
| 5119 |
VELCADE/Dexamethasone (Vel/D) Versus VAD as Induction Treatment Prior to Autologous Stem Cell Transplantion (ASCT) in Newly Diagnosed Multiple Myeloma (MM): Updated Results of the IFM 2005/01 Trial.
|
Harousseau, Jean Luc
|
|
|
110 |
11 |
p. 450
|
artikel
|
| 5120 |
Velcade®, Thalidomide, Dexamethasone (VTD) Induction Therapy Followed by Melphalan, Prednisone, Thalidomide (MPT) Maintenance as a First Line Treatment for the Patients (pts) with Multiple Myeloma (MM) Who Are Non-Transplant Candidates: Early Analysis from the Korean Multiple Myeloma Working Party.
|
Eom, HyeonSeok
|
|
|
110 |
11 |
p. 4831
|
artikel
|
| 5121 |
Venom-Derived Factor V from the Common Brown Snake P. Textilis Is Expressed as a Constitutively Active Cofactor.
|
Bos, Mettine H.A.
|
|
|
110 |
11 |
p. 1765
|
artikel
|
| 5122 |
Venothromboembolism (VTE) in Patients (pts) with Acute Lymphocytic Leukemia (ALL), Burkitt's Leukemia/Lymphoma (BL) or Lymphoblastic Lymphoma (LL).
|
Vu, Khanh D.
|
|
|
110 |
11 |
p. 4338
|
artikel
|
| 5123 |
Venous Thromboembolic Events in Women Using the NuvaRing®.
|
Shum, Merrill K.
|
|
|
110 |
11 |
p. 3994
|
artikel
|
| 5124 |
Venous Thromboembolic Risk and Suboptimal Prophylaxis in the US Acute Hospital Care Setting: Findings from the ENDORSE Study.
|
Tapson, Victor F.
|
|
|
110 |
11 |
p. 1858
|
artikel
|
| 5125 |
Venous Thromboembolism among 1,570 Patients Undergoing Hematopoietic Stem Cell Transplantation: Incidence, Risk Factors, Treatment and Outcomes.
|
Gerber, David E.
|
|
|
110 |
11 |
p. 1628
|
artikel
|
| 5126 |
Venous Thromboembolism and Non-Small Cell Lung Cancer: A Pooled Analysis of National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) Trials.
|
Hicks, Lisa
|
|
|
110 |
11 |
p. 3995
|
artikel
|
| 5127 |
Venous Thromboembolism in Lymphoma: How Effectively Are We Treating Patients?.
|
Muslimani, Alaa A.
|
|
|
110 |
11 |
p. 1878
|
artikel
|
| 5128 |
Very High Birth Weight of Offspring Is Associated with an Increased Risk of Leukemia in Their Mothers; Results of a Population-Based Cohort Study.
|
Paltiel, Ora
|
|
|
110 |
11 |
p. 4677
|
artikel
|
| 5129 |
Very High Expression of MGMT(P140K) Paradoxically Impairs Proliferation, In Vivo Selection and Protection of Transduced Hematopoietic Stem Cells.
|
Milsom, Michael D.
|
|
|
110 |
11 |
p. 2588
|
artikel
|
| 5130 |
Vigorous Priming of Minor Histocompatibility Antigen Specific T Cells by Frequent High Dose Peptide Vaccination May Lead to Prolonged T Cell Receptor Downregulation, Impaired T Cell Functionality, and Promotion of Tumor Escape.
|
Jedema, Inge
|
|
|
110 |
11 |
p. 1809
|
artikel
|
| 5131 |
Viral Genome Scan for Analysis of CMV-Specific CD8+ T Cells in Normal and Immunocompromised Individuals.
|
Manley, Thomas J.
|
|
|
110 |
11 |
p. 1068
|
artikel
|
| 5132 |
Vitamin D Deficiency Is Associated with Cardiac Iron Loading in Thalassemia Major.
|
Wood, John C.
|
|
|
110 |
11 |
p. 574
|
artikel
|
| 5133 |
Vitamin D Receptor (VDR) Polymorphisms in Chronic Lymphocytic Leukaemia (CLL) Patients.
|
Kwa, Faith
|
|
|
110 |
11 |
p. 4689
|
artikel
|
| 5134 |
Vitamin E Isoforms Inhibit Cell Proliferation and Downregulate Homeobox Protein Expression in the Leukemic KG-1 Cells.
|
Saba, Nakhle S.
|
|
|
110 |
11 |
p. 4304
|
artikel
|
| 5135 |
Vitamin K2 Induces Autophagy and Apoptosis Simultaneously in Leukemia Cells and Bcl-2 Expression Level Determines the Phenotype of Their Cell Death.
|
Miyazawa, Keisuke
|
|
|
110 |
11 |
p. 3478
|
artikel
|
| 5136 |
von Willebrand Disease in Chronic Immune Thrombocytopenic Purpura Children.
|
Lee, Ji Hye
|
|
|
110 |
11 |
p. 3954
|
artikel
|
| 5137 |
Von Willebrand Disease in Taiwan: A Clinical and Laboratory Studies of 52 Patients.
|
Chen, Yeu-Chin
|
|
|
110 |
11 |
p. 3974
|
artikel
|
| 5138 |
Von Willebrand Disease (VWD) - A Disease with Dual Factor Deficiencies- Discrepant FVIII:C Pharmacokinetic (PK) Characteristics in a Head to Head Trial of Two VWF/FVIII Concentrates.
|
Kessler, Craig M.
|
|
|
110 |
11 |
p. 2141
|
artikel
|
| 5139 |
von Willebrand Factor/Factor VIII (VWF/FVIII) Concentrate Is Safe and Effective for Management of Elective Surgery in Adults and Children with von Willebrand Disease (VWD): Combined Results of United States (US) and European (EU) Studies.
|
Gill, Joan Cox
|
|
|
110 |
11 |
p. 2142
|
artikel
|
| 5140 |
Vorinostat in Combination with Other Agents for Therapy of Cutaneous T-Cell Lymphomas: A Case Series.
|
Geskin, Larisa J.
|
|
|
110 |
11 |
p. 4482
|
artikel
|
| 5141 |
Vorinostat (SAHA) Inhibits STAT6 Phosphorylation and Transcription, Downregulates Bcl-xL, and Induces Apoptosis in Hodgkin Lymphoma (HL) Cell Lines.
|
Buglio, Daniela
|
|
|
110 |
11 |
p. 380
|
artikel
|
| 5142 |
Vorinostat (Suberoylanilide Hydroxamic Acid) in Relapsed or Refractory Hodgkin Lymphoma: SWOG 0517.
|
Kirschbaum, Mark H.
|
|
|
110 |
11 |
p. 2574
|
artikel
|
| 5143 |
Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Provides Prolonged Safety and Clinical Benefit to Patients with Advanced Cutaneous T-Cell Lymphoma (CTCL).
|
Duvic, Madeleine
|
|
|
110 |
11 |
p. 2582
|
artikel
|
| 5144 |
Vorinostat Synergistically Potentiates MK-0457 Lethality in Chronic Myelogenous Leukemia (CML) Cells Sensitive and Resistant to Imatinib Mesylate.
|
Dai, Yun
|
|
|
110 |
11 |
p. 1041
|
artikel
|
| 5145 |
Vβ Spectratype Analysis of Tissue-Infiltrating T Cells Responding to Minor Histocompatibility Antigens Involved in Graft-Versus-Host Disease.
|
Zilberberg, Jenny
|
|
|
110 |
11 |
p. 3244
|
artikel
|
| 5146 |
VWF Concentrates - Does Size Really Matter - Von Willebrand Factor Function under Physiological Flow Conditions.
|
Schwartz, Bruce A.
|
|
|
110 |
11 |
p. 3138
|
artikel
|
| 5147 |
Waiting for Godot: Thirty-Six Month Follow-Up on Accelerated FDA Approval of Drugs To Treat Hematologic Malignancies.
|
Shankaran, Veena
|
|
|
110 |
11 |
p. 3340
|
artikel
|
| 5148 |
Waldenström Macroglobulinaemia: The Impact of Cytogenetic Analysis.
|
Jimenez-Zepeda, Victor H.
|
|
|
110 |
11 |
p. 2490
|
artikel
|
| 5149 |
WBC Differential by Flow Cytometry: The First Routine Application in a Large University Hospital Clinical Laboratory.
|
Roussel, Mikael
|
|
|
110 |
11 |
p. 3845
|
artikel
|
| 5150 |
What Have We Learned from Measuring Health-Related Quality of Life in Patients with Chronic Lymphocytic Leukemia? A Systematic Review of Published Studies from 1990 to 2007.
|
Molica, Stefano
|
|
|
110 |
11 |
p. 4718
|
artikel
|
| 5151 |
What Is the Role for Donor NK Cells after Nonmyeloablative Conditioning?
|
Baron, Frederic
|
|
|
110 |
11 |
p. 476
|
artikel
|
| 5152 |
When May Patients Be Considered Cured after Autografting for Hodgkin Lymphoma?.
|
Dean, Robert M.
|
|
|
110 |
11 |
p. 1909
|
artikel
|
| 5153 |
Which Strategy of Immunoablative Therapy with Autologous Stem Cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.
|
Shevchenko, Yury L.
|
|
|
110 |
11 |
p. 5093
|
artikel
|
| 5154 |
WHO Classification and WPSS Score Predict Post-Transplant Outcome in Adults with Myelodysplastic Syndrome: A Retrospective Study by GITMO - Gruppo Italiano Trapianto Midollo Osseo.
|
Alessandrino, Paolo E.
|
|
|
110 |
11 |
p. 1466
|
artikel
|
| 5155 |
Who Gets Inhibitors? Predicting Inhibitory Antibodies in Children with Severe Hemophilia A.
|
ter Avest, Petra C.
|
|
|
110 |
11 |
p. 1158
|
artikel
|
| 5156 |
Whole Blood Gene Expression Profiles Distinguish Patients with Single Prior Venous Thromboembolism from Patients with Multiple Prior Events.
|
Akay, Olga M.
|
|
|
110 |
11 |
p. 1630
|
artikel
|
| 5157 |
Whole Genome Association Study in Acute Myeloid Leukemia with a Normal Karyotype, Using a Single-Nucleotide Polymorphism (SNP) Analysis.
|
Cha, Yongjun
|
|
|
110 |
11 |
p. 4253
|
artikel
|
| 5158 |
Whole Genome Association Study in Leukemia: Frequent Loss of Heterozygosity (LOH) and Single Nucleotide Polymorphism (SNP) in Acute Myeloid Leukemia with a Normal Karyotype.
|
Lee, Young Y.
|
|
|
110 |
11 |
p. 2838
|
artikel
|
| 5159 |
Wilm's Tumor 1 Gene Expression Is a Useful Marker for Minimal Residual Disease in Acute Myeloid Leukemia.
|
Hsu, Jack W.
|
|
|
110 |
11 |
p. 4240
|
artikel
|
| 5160 |
Wilms Tumor 1 Gene (WT1) Isoforms in Leukemia and Lymphoma.
|
Li, Aihong
|
|
|
110 |
11 |
p. 4265
|
artikel
|
| 5161 |
Wilms Tumor 1 (WT1) Gene Mutations Predict Poor Outcome in Adults with Cytogenetically Normal (CN) Acute Myeloid Leukemia (AML): A Cancer and Leukemia Group B (CALGB) Study.
|
Paschka, Peter
|
|
|
110 |
11 |
p. 362
|
artikel
|
| 5162 |
Wireless Capsule Endoscopy (WCE) Is an Important Diagnostic and Management Tool of Gastrointestinal (GI) Acute and Chronic Graft Versus Host Disease (GVHD) after Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) and Identifies Gastroparesis as a Prominent Complication of GI GVHD.
|
Varadarajan, Prakash
|
|
|
110 |
11 |
p. 2985
|
artikel
|
| 5163 |
Wnt/β-Catenin Signaling Is Essential for the Transdifferentiation of Monocytes into Endothelial Cells by mCSF and Pleiotrophin.
|
Chen, Haiming
|
|
|
110 |
11 |
p. 1512
|
artikel
|
| 5164 |
Wnt3/RhoA/ROCK Signaling Pathway Is Involved in VLA6-Dependent Adhesion-Mediated Drug Resistance of Multiple Myeloma.
|
Kobune, Masayoshi
|
|
|
110 |
11 |
p. 2518
|
artikel
|
| 5165 |
Wolinella Asparaginase as an Immunologically Distinct, Efficacious, and Potentially Less Toxic Asparaginase for Use in Lymphoid Malignancies.
|
Watt, Tanya C.
|
|
|
110 |
11 |
p. 861
|
artikel
|
| 5166 |
WT1 Interaction with the Chaperone Protein HSP90 Regulates Its Expression in Myeloid Leukemia.
|
Bansal, Sanjay
|
|
|
110 |
11 |
p. 1826
|
artikel
|
| 5167 |
Xanthohumol: A New Potential Proteasome Inhibitor That Activates the Pro-Apoptotic Arm of the Unfolded Protein Response in B-CLL Cells.
|
Lust, Sofie
|
|
|
110 |
11 |
p. 4694
|
artikel
|
| 5168 |
XBP-1 Levels Predict Sensitivity of Myelomas to Proteasome Inhibitor Bortezomib.
|
Ling, Silvia C.
|
|
|
110 |
11 |
p. 1473
|
artikel
|
| 5169 |
X-Linked Sideroblastic Anemia Is a Rare Cause of Microcytosis and Iron Overload in Adults: About 3 Cases with 2 New ALAS2 Gene Mutations Improved after Iron Chelation by Phlebotomy.
|
Touati, Mohamed
|
|
|
110 |
11 |
p. 4619
|
artikel
|
| 5170 |
XmAb™2513, an Fc Engineered Humanized Anti-CD30 Monoclonal Antibody, Has Potent In Vitro and In Vivo Activities, and Has the Potential for Treating Hematologic Malignancies.
|
Lawrence, Chris E.
|
|
|
110 |
11 |
p. 2340
|
artikel
|
| 5171 |
XmAb™ Fc Engineered Anti-CD19 Monoclonal Antibody with Enhanced In Vitro Efficacy Against Lymphoma and Leukemia.
|
Zhukovsky, Eugene
|
|
|
110 |
11 |
p. 2335
|
artikel
|
| 5172 |
Y-Chromosome Genes Strongly Expressed in Acute Myeloid Leukaemia.
|
Gallo, Antonio
|
|
|
110 |
11 |
p. 4901
|
artikel
|
| 5173 |
10 Year Musculoskeletal Outcomes with Tailored Primary Prophylaxis: The Canadian Hemophilia Prophylaxis Study.
|
Blanchette, Victor S.
|
|
|
110 |
11 |
p. 84
|
artikel
|
| 5174 |
Y-90 Ibritumomab Tiuxetan as Consolidation Following Three Cycles of Fludarabine-Cyclophosphamide-Rituximab Chemoimmunotherapy in Patients with Relapsed Follicular, Indolent or Mantle-Cell Lymphoma: A Prospective “Dose”-Finding Study.
|
von Schilling, Christoph
|
|
|
110 |
11 |
p. 3426
|
artikel
|
| 5175 |
90Y-Ibritumomab Tiuxetan (Zevalin®) Consolidation of First Remission in Advanced Stage Follicular Non-Hodgkin's Lymphoma: First Results of the International Randomized Phase 3 First-Line Indolent Trial (FIT) in 414 Patients.
|
Hagenbeek, Anton
|
|
|
110 |
11 |
p. 643
|
artikel
|
| 5176 |
90Y-Ibritumomab Treatment for Relapsed and/or Refractory B Cell Type Non-Hodgkin's Lymphoma. Multiinstitutional Argentinian Study.
|
Cacchione, Roberto
|
|
|
110 |
11 |
p. 4484
|
artikel
|
| 5177 |
90Y-Ibtritumomab as a Single Agent for De Novo or Transformed Diffuse Large B Cell Lymphoma.
|
Ali, Syed S.
|
|
|
110 |
11 |
p. 4505
|
artikel
|
| 5178 |
YRRL Motifs in the Cytoplasmic Domain of the Thrombopoietin Receptor Mpl Regulate Receptor Internalization and Degradation.
|
Hitchcock, Ian S.
|
|
|
110 |
11 |
p. 90
|
artikel
|
| 5179 |
90Yttrium Ibritumomab Tiuxetan (Zevalin) Combined with BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Follicular Lymphoma. GELA Phase II Study.
|
Gisselbrecht, Christian
|
|
|
110 |
11 |
p. 22
|
artikel
|
| 5180 |
90Y-Zevalin® (90Y-Ibritumomab Tiuxetan) Radioimmunotherapy (RIT) Consolidation in Mantle Cell Lymphoma (MCL) Patients, Not Illegible for Intensive Therapy Protocols.
|
Jurczak, Wojciech
|
|
|
110 |
11 |
p. 4497
|
artikel
|
| 5181 |
Zanolimumab (HuMax-CD4™), a Fully Human Monoclonal Antibody: Efficacy and Safety in Patients with Relapsed or Treatment-Refractory Non-Cutaneous CD4+ T-Cell Lymphoma.
|
d'Amore, Francesco
|
|
|
110 |
11 |
p. 3409
|
artikel
|
| 5182 |
ZAP70 Expression by Immunohistochemistry Correlates with IgVH Mutation Status in Chronic Lymphocytic Leukemia and Predicts Time to Progression, but Survival Is Decreased in p53-Positive CLL, Regardless of ZAP70 Expression.
|
Schlette, Ellen J.
|
|
|
110 |
11 |
p. 3083
|
artikel
|
| 5183 |
ZAP-70 Expression in Chronic Lymphocytic Leukemia Is Associated with Altered Signal Transduction.
|
Wolniak, Kristy L.
|
|
|
110 |
11 |
p. 4702
|
artikel
|
| 5184 |
Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.
|
Alousi, Amin M.
|
|
|
110 |
11 |
p. 620
|
artikel
|
| 5185 |
ZFP143 Activates C/EBPα Transcription in Myeloid Cells.
|
Bartholdy, Boris
|
|
|
110 |
11 |
p. 1233
|
artikel
|
| 5186 |
Zinc Enhances the Protection of Fibrin-Bound Thrombin from Antithro Inhibition.
|
Chan, Howard H.W.
|
|
|
110 |
11 |
p. 2691
|
artikel
|
| 5187 |
Zoledronic Acid Increases Bone Mineral Density in Patients with Thalassemia Intermedia-Induced Osteoporosis Regardless of the Incessant Bone Marrow Expansion.
|
Voskaridou, Ersi
|
|
|
110 |
11 |
p. 3813
|
artikel
|
| 5188 |
Zoledronic Acid Suppresses Vasculogenesis: A New Effect of Bisphosphonates.
|
Chen, Haiming
|
|
|
110 |
11 |
p. 3913
|
artikel
|
| 5189 |
Zoledronic Acid (ZOL) Markedly Improves Bone Mineral Density (BMD) for Patients (Pts) with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Bone Loss.
|
Berenson, James R.
|
|
|
110 |
11 |
p. 3606
|
artikel
|
| 5190 |
Zygomycosis: A Severe Fungal Infection with Challenging Diagnostic Difficulties: A Case with Cardiac Involvement without Cardiac Symptoms.
|
Madeira, Maria I.A.
|
|
|
110 |
11 |
p. 5019
|
artikel
|
Tijdschrift beschrijving